Pacer Advisors
ALNY icon

Pacer Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Pacer Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Buy
7,982
+3,504
+78% +$1.06M 0.01% 928
2026
Q1 		$1.48M Sell
4,478
-5,110
-53% -$1.74M ﹤0.01% 1065
2025
Q4 		$3.81M Buy
+9,588
New +$4.24M 0.01% 810
2024
Q3 		– Sell
-461
Closed -$112K – 2561
2024
Q2 		$112K Buy
461
+176
+62% +$27.8K ﹤0.01% 2233
2024
Q1 		$42.6K Buy
+285
New +$47.5K ﹤0.01% 3233
2021
Q2 		– Sell
-550
Closed -$78K – 1409
2021
Q1 		$78K Sell
550
-472
-46% -$71K ﹤0.01% 1326
2020
Q4 		$133K Buy
1,022
+184
+22% +$24.6K ﹤0.01% 1312
2020
Q3 		$122K Buy
+838
New +$119K ﹤0.01% 1233
2018
Q4 		– Sell
-2,640
Closed -$231K – 553
2018
Q3 		$231K Buy
+2,640
New +$266K 0.01% 1001
2018
Q1 		– Sell
-1,525
Closed -$194K – 1042
2017
Q4 		$194K Sell
1,525
-10,241
-87% -$1.29M 0.01% 908
2017
Q3 		$1.38M Buy
11,766
+156
+1% +$13.3K 0.12% 158
2017
Q2 		$926K Buy
11,610
+2,093
+22% +$134K 0.09% 274
2017
Q1 		$488K Buy
9,517
+1,544
+19% +$71.4K 0.06% 494
2016
Q4 		$299K Buy
7,973
+386
+5% +$16.2K 0.04% 694
2016
Q3 		$514K Buy
7,587
+657
+9% +$46.4K 0.08% 353
2016
Q2 		$385K Buy
6,930
+5,790
+508% +$365K 0.06% 451
2016
Q1 		$72K Buy
1,140
+55
+5% +$3.66K 0.02% 712
2015
Q4 		$102K Buy
+1,085
New +$101K 0.02% 580

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pacer Advisors's ALNY Position: Q2 2026 in Review

Pacer Advisors increased its Alnylam Pharmaceuticals (ALNY) stake by 78% in Q2 2026, buying an estimated $1.06M and bringing the position to 7,982 shares worth $2.4M. The position accounts for 0.01% of the portfolio, ranked #928.

Pacer Advisors first reported a position in ALNY in Q4 2015 and has held it in 18 quarters since. The position peaked at $3.81M in Q4 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Pacer Advisors held 7,982 shares of Alnylam Pharmaceuticals worth $2.4M as of Q2 2026.
  • Pacer Advisors bought 3,504 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $1.06M.
  • Alnylam Pharmaceuticals made up 0.01% of Pacer Advisors's portfolio in Q2 2026, its #928 holding.
  • Pacer Advisors first reported a position in Alnylam Pharmaceuticals in Q4 2015 and has held it in 18 quarters since.
  • Pacer Advisors's Alnylam Pharmaceuticals position peaked at $3.81M in Q4 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.